An adjustable inhalation device

Abstract

This utility model provides an adjustable inhalation medication device, belonging to the field of pharmaceutical equipment technology. It includes a limiting disc and an adjustment assembly disposed inside the limiting disc. The adjustment assembly includes a main column, a medication cartridge holder, a spray button, a one-way air inlet valve, a metal knob, an indicator ball, a medication cartridge nozzle, and a suction mouthpiece. The main column is embedded inside the limiting disc, and the medication cartridge holder is fixedly disposed at the bottom of the outer wall of the main column. The adjustment assembly, through active inhalation and simultaneous pressing, sprays the medication, ensuring that the medication reaches the respiratory system with the airflow. This solves the problem of insufficient medication inhalation when the patient's breathing is inadequate. It features high inhalation efficiency and ease of operation, focusing on improving drug absorption, preventing drug waste and contamination, combining multiple therapeutic functions, and enhancing ease of use and stability to meet clinical treatment needs and improve treatment efficacy and patient experience.

Description

Technical Field

[0001] This utility model belongs to the field of pharmaceutical equipment technology, specifically relating to an adjustable inhalation pharmaceutical device. Background Technology

[0002] In the medical field, inhaled drug therapy is an important treatment method, especially widely used in the treatment of respiratory diseases and postoperative respiratory diseases. Its principle is to disperse medication into tiny droplets or particles, suspending them in a gas, which are then inhaled into the respiratory tract and lungs, thereby achieving the goals of airway cleansing, expectoration, local treatment, and systemic therapy. Inhalation allows medication to act directly on the respiratory system, offering advantages over traditional oral or injectable administration methods, such as smaller dosages, rapid onset of action, and fewer systemic side effects.

[0003] However, traditional inhalation devices have many problems. Their complex structure, high degree of electronic integration, difficulty in operation, lack of feedback, and insufficient inhalation all affect drug absorption and reduce therapeutic efficacy. For example, some aerosol inhalers lack unidirectional inhalation functionality, allowing the patient's exhaled air to easily enter the inhaler and mix with the medication, affecting the judgment of the inhaled dosage, etc. Utility Model Content

[0004] The purpose of this invention is to provide an adjustable inhalation medication device, which aims to solve the problems mentioned in the background art.

[0005] An adjustable inhalation medication device includes,

[0006] Limit plate;

[0007] An adjustment assembly is located inside the limiting plate, comprising: a main column, a core cartridge holder, a spray button, a one-way air intake valve, a metal knob, an indicator ball, a core cartridge nozzle, and a suction nozzle. The main column is embedded inside the limiting plate. The core cartridge holder is fixedly installed at the bottom of the outer wall of the main column. The spray button is embedded inside the core cartridge holder. The one-way air intake valve is connected to one end of the main column. The core cartridge nozzle is connected to the core cartridge holder. The suction nozzle is embedded inside the other end of the main column. The indicator ball is slidably embedded inside the main column. The metal knob is sleeved on the outer wall of the one-way air intake valve.

[0008] Furthermore, the outer wall of the main column is provided with graduations.

[0009] Furthermore, a movable platform is fixedly installed on the top of the outer wall of the main column.

[0010] Furthermore, a limiting groove is provided at the top axis of the outer wall of the mobile platform.

[0011] Furthermore, a limiting block is slidably embedded inside the limiting groove.

[0012] Furthermore, an observation mirror is rotatably inserted into the top of the outer wall of the limiting block.

[0013] Compared with the prior art, the beneficial effects of this utility model are:

[0014] The adjustable components allow for active inhalation and simultaneous pressure-activated drug delivery, ensuring the medication reaches the respiratory system via airflow. This addresses the issue of insufficient drug inhalation when patients' breathing is inadequate. The device features high drug inhalation efficiency and ease of operation, focusing on improving drug absorption, preventing waste and contamination, combining multiple therapeutic functions, and enhancing usability and stability to meet clinical treatment needs and improve treatment outcomes and patient experience. Attached Figure Description

[0015] The accompanying drawings are provided to further illustrate the present invention and form part of the specification. They are used together with the embodiments of the present invention to explain the present invention, but do not constitute a limitation thereof. In the drawings:

[0016] Figure 1 This is a perspective view of the present utility model;

[0017] Figure 2 This is a perspective view of the indicator ball of this utility model;

[0018] Figure 3 This is a perspective view of the limiting plate of this utility model.

[0019] In the diagram: 1. Limiting plate; 2. Main column; 3. Core cartridge holder; 4. Injection button; 5. One-way air intake valve; 6. Metal knob; 7. Indicator ball; 8. Core cartridge nozzle; 9. Moving stage; 10. Suction nozzle; 11. Limiting block; 12. Observation mirror; 201. Limiting groove; 202. Scale. Detailed Implementation

[0020] The technical solutions of the present utility model will be clearly and completely described below with reference to the accompanying drawings of the embodiments. Obviously, the described embodiments are only some embodiments of the present utility model, and not all embodiments. Based on the embodiments of the present utility model, all other embodiments obtained by those of ordinary skill in the art without creative effort are within the protection scope of the present utility model.

[0021] In the description of this utility model, it should be noted that the terms "upper," "lower," "inner," "outer," "top / bottom," etc., indicating the orientation or positional relationship are based on the orientation or positional relationship shown in the accompanying drawings, and are only for the convenience of describing this utility model and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific orientation, or be constructed and operated in a specific orientation, and therefore should not be construed as a limitation of this utility model. Furthermore, the terms "first" and "second" are used for descriptive purposes only and should not be construed as indicating or implying relative importance.

[0022] In the description of this utility model, it should be noted that, unless otherwise explicitly specified and limited, the terms "installed," "equipped with," "sleeved / connected," "connected," etc., should be interpreted broadly. For example, "connection" can be a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be a direct connection or an indirect connection through an intermediate medium; it can be a connection within two components. Those skilled in the art can understand the specific meaning of the above terms in this utility model based on the specific circumstances.

[0023] Please see Figure 1-3 The technical solution provided in this embodiment is as follows:

[0024] An adjustable inhalation medication device includes,

[0025] Limit plate 1;

[0026] An adjustment assembly is located inside the limiting plate 1. The adjustment assembly includes a main column 2, a core cartridge holder 3, an injection button 4, a one-way air intake valve 5, a metal knob 6, an indicator ball 7, a core cartridge nozzle 8, and a suction nozzle 10. The main column 2 is embedded inside the limiting plate 1. The core cartridge holder 3 is fixedly installed at the bottom of the outer wall of the main column 2. The injection button 4 is embedded inside the core cartridge holder 3. The one-way air intake valve 5 is connected to one end of the main column 2. The core cartridge nozzle 8 is connected to the core cartridge holder 3. The suction nozzle 10 is embedded inside the other end of the main column 2. The indicator ball 7 is slidably embedded inside the main column 2. The metal knob 6 is sleeved on the outer wall of the one-way air intake valve 5.

[0027] In a specific embodiment of this utility model, the adjustment component allows for active inhalation and simultaneous pressing of the sprayed medication, enabling the medication to reach the respiratory system with the airflow. This solves the problem of insufficient medication inhalation when the patient's breathing is not up to standard. It features high medication inhalation efficiency and ease of operation, focusing on improving drug absorption, preventing drug waste and contamination, combining multiple therapeutic functions, and enhancing ease of use and stability to meet clinical treatment needs and improve treatment efficacy and patient experience. Using the handles protruding from both sides of the outer wall of the limiting disc 1 for support, blow air into the cavity through the mouthpiece 10 to test the airtightness; after confirming that the airtightness is not a problem, perform an inhalation process to test whether the indicator ball 7 can rise normally and whether the inhalation resistance generated by the one-way air inlet valve 5 is appropriate; then press the spray button 4 to confirm whether the medicine can be sprayed normally; during the use stage, after a deep exhalation, slowly inhale through the mouth and mouth through the mouthpiece 10. When you see the indicator ball 7 rise, press the spray button 4, keep the indicator ball 7 above the target indicator scale 202, and continue inhaling. Hold your breath when the spray in the cavity disappears to complete the medicine inhalation process; exhale slowly through the nose without leaving the mouth and observe the small If the lens fogs up, after the exhalation process is completed, an inhalation and exhalation process without pressing the spray button will begin, ending the single inhalation of medication. The inspiratory muscle stimulation training function does not require pressing the spray button 4; the appropriate inspiratory resistance can be selected by adjusting the metal knob. When not in use, disassemble all components for cleaning and storage. During inhalation, due to airflow and pressure, the indicator ball 7 rises, and the outer wall of the transparent stimulation tube has a scale 202 indicating the direction. At this time, pressing the spray button 4 sprays the medication, which enters the patient's airway with the inspiratory airflow. Continuing to allow the patient to inhale while keeping the indicator ball 7 at a certain scale 202 completes a deep and slow inhalation process, ensuring the medication fully enters the respiratory system. During exhalation, the patient exhales through the nose. The expiratory airflow can be observed through the observation mirror 12 next to the mouthpiece 10, which confirms whether exhalation is through the nose and allows observation of how the medication is expelled with the airflow.A seal test is performed by blowing air into the main column 2 through the mouthpiece 10. After confirming that the seal is secure, an inhalation process is conducted to check whether the indicator bulb 7 can rise normally and whether the inhalation resistance generated by the one-way air inlet valve 5 is appropriate. Then, the spray button 4 is pressed to install the medication cartridge into the medication cartridge holder 3, confirming that the medication in the cartridge can be sprayed normally. During use, after a deep exhalation, slowly inhale through the mouthpiece 10. When the indicator bulb 7 rises, press the spray button 4, keep the indicator bulb 7 above the target indicator mark 202, and continue inhaling. Hold your breath when the spray in the tube disappears to complete the medication inhalation process. Exhale slowly through the nose without removing your mouth from the mouthpiece 10. Visually observe the fogging of the observation mirror 12. After completing the exhalation process, proceed with an inhalation and exhalation process without pressing the spray button. The single inhalation process ends. The inspiratory muscle stimulation training function does not require pressing the spray button 4; the appropriate inspiratory resistance can be selected via the metal knob 6. When not in use, disassemble all components for cleaning and storage. During inhalation, due to airflow and pressure, the indicator ball 7 rises, indicating the scale 202 on the limit plate 1. At this point, pressing the spray button 4 releases the medication, which enters the patient's airway with the inspiratory airflow. Continue inhaling while keeping the indicator ball 7 at a specific scale 202, completing a deep and slow inhalation process, thus ensuring the medication fully enters the respiratory system. During exhalation, the patient exhales through the nose. The exhalation airflow can be observed through the observation mirror 12 next to the mouthpiece 10. This confirms whether the exhalation is through the nose and allows observation of how the medication is expelled with the airflow.

[0028] Specifically, the outer wall of the main column 2 has a scale 202.

[0029] In a specific embodiment of this utility model, the scale 202 can assist in reading the height of the indicator ball 7.

[0030] Specifically, a movable platform 9 is fixedly installed on the top of the outer wall of the main column 2.

[0031] In a specific embodiment of this utility model, a movable platform 9 is fixedly provided on the top of the outer wall of the main column 2, which facilitates installation.

[0032] Specifically, a limiting groove 201 is provided at the top axis of the outer wall of the moving platform 9.

[0033] In a specific embodiment of this utility model, the limiting groove 201 facilitates the movement of the limiting block 11.

[0034] Specifically, a limiting block 11 is slidably embedded inside the limiting groove 201.

[0035] In a specific embodiment of this utility model, the limiting block 11 can ensure the stability of movement.

[0036] Specifically, an observation mirror 12 is rotatably inserted into the top of the outer wall of the limiting block 11.

[0037] In a specific embodiment of this utility model, the observation mirror 12 can be used to observe the fogging of breathing.

[0038] Working principle:

[0039] The adjustable components, combined with active inhalation and press-to-inhale medication, ensure the medication reaches the respiratory system via airflow, addressing insufficient medication inhalation when patients' breathing is inadequate. It features high medication inhalation efficiency and ease of operation, focusing on improving drug absorption, preventing waste and contamination, integrating multiple therapeutic functions, and enhancing usability and stability to meet clinical needs and improve treatment efficacy and patient experience. A seal test is performed by blowing air into the lumen through the mouthpiece 10. After confirming a good seal, an inhalation process is conducted to check if the indicator bulb 7 rises normally and if the inhalation resistance generated by the one-way inlet valve 5 is appropriate. Then, the injection button 4 is pressed to confirm proper medication dispensing. During use, after a deep exhalation, slowly inhale through the mouthpiece 10. When the indicator bulb 7 rises, press the injection button 4, keeping the indicator bulb 7 above the target reading of 202, and continue inhaling. Hold your breath when the spray in the lumen disappears to complete the medication inhalation process. Exhale slowly through the nose without removing the mouthpiece 10, observing fogging of the small lens to complete the exhalation process. After the initial inhalation, a non-press-press inhalation and exhalation process follows, ending a single inhalation. The inspiratory muscle stimulation training function does not require pressing the spray button 4; the appropriate inspiratory resistance can be selected by adjusting the metal knob. When not in use, disassemble all components for cleaning and storage. During inhalation, due to airflow and pressure, the indicator bulb 7 rises, and the transparent stimulation tube has a scale 202 on its outer wall. At this time, pressing the spray button 4 releases the medication, which enters the patient's airway with the inspiratory airflow. Continuing to inhale while keeping the indicator bulb 7 at a certain scale 202 completes a deep and slow inhalation process, ensuring the medication fully enters the respiratory system. During exhalation, the patient exhales through the nose. The expiratory airflow can be observed through the observation mirror 12 next to the mouthpiece 10, confirming whether exhalation is through the nose and observing how the medication is expelled with the airflow.A seal test is performed by blowing air into the main column 2 through the mouthpiece 10. After confirming that the seal is secure, an inhalation process is conducted to check whether the indicator bulb 7 can rise normally and whether the inhalation resistance generated by the one-way air inlet valve 5 is appropriate. Then, the spray button 4 is pressed to install the medication cartridge into the medication cartridge holder 3, confirming that the medication in the cartridge can be sprayed normally. During use, after a deep exhalation, slowly inhale through the mouthpiece 10. When the indicator bulb 7 rises, press the spray button 4, keep the indicator bulb 7 above the target indicator mark 202, and continue inhaling. Hold your breath when the spray in the tube disappears to complete the medication inhalation process. Exhale slowly through the nose without removing your mouth from the mouthpiece 10. Visually observe the fogging of the observation mirror 12. After completing the exhalation process, proceed with an inhalation and exhalation process without pressing the spray button. The single inhalation process ends. The inspiratory muscle stimulation training function does not require pressing the spray button 4; the appropriate inspiratory resistance can be selected via the metal knob 6. When not in use, disassemble all components for cleaning and storage. During inhalation, due to airflow and pressure, the indicator ball 7 rises, indicating the scale 202 on the limit plate 1. At this point, pressing the spray button 4 releases the medication, which enters the patient's airway with the inspiratory airflow. Continue inhaling while keeping the indicator ball 7 at a specific scale 202, completing a deep and slow inhalation process, thus ensuring the medication fully enters the respiratory system. During exhalation, the patient exhales through the nose. The exhalation airflow can be observed through the observation mirror 12 next to the mouthpiece 10. This confirms whether the exhalation is through the nose and allows observation of how the medication is expelled with the airflow.

[0040] Finally, it should be noted that the above description is merely a preferred embodiment of this utility model and is not intended to limit the utility model. Although the utility model has been described in detail with reference to the foregoing embodiments, those skilled in the art can still modify the technical solutions described in the foregoing embodiments or make equivalent substitutions for some of the technical features. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of this utility model should be included within the protection scope of this utility model.

Claims

1. An adjustable inhalation device, characterized in that, include, Limiting plate (1); An adjustment assembly is located inside the limiting plate (1), wherein: the adjustment assembly includes a main column (2), a core cartridge holder (3), an injection button (4), a one-way air intake valve (5), a metal knob (6), an indicator ball (7), a core cartridge nozzle (8), and a suction nozzle (10). The main column (2) is embedded inside the limiting plate (1). The core cartridge holder (3) is fixedly set at the bottom of the outer wall of the main column (2). The injection button (4) is embedded inside the core cartridge holder (3). The one-way air intake valve (5) is connected to one end of the main column (2). The core cartridge nozzle (8) is connected to the core cartridge holder (3). The suction nozzle (10) is embedded inside the other end of the main column (2). The indicator ball (7) is slidably embedded inside the main column (2). The metal knob (6) is sleeved on the outer wall of the one-way air intake valve (5).

2. The adjustable inhalation device according to claim 1, characterized in that, The outer wall of the main column (2) is provided with a scale (202).

3. An adjustable inhalation device according to claim 2, characterized in that, A movable platform (9) is fixedly installed on the top of the outer wall of the main column (2).

4. An adjustable inhalation medication device according to claim 3, characterized in that, A limiting groove (201) is provided at the top axis of the outer wall of the mobile platform (9).

5. An adjustable inhalation medication device according to claim 4, characterized in that, The limiting groove (201) is internally fitted with a limiting block (11).

6. An adjustable inhalation medication device according to claim 5, characterized in that, An observation mirror (12) is rotatably inserted into the top of the outer wall of the limiting block (11).

Images